Related references
Note: Only part of the references are listed.Rituximab in Membranous Nephropathy
Philipp Gauckler et al.
KIDNEY INTERNATIONAL REPORTS (2021)
The STARMEN trial indicates that alternating treatment with corticosteroids and cyclophosphamide is superior to sequential treatment with tacrolimus and rituximab in primary membranous nephropathy
Gema Fernandez-Juarez et al.
KIDNEY INTERNATIONAL (2021)
New insight into podocyte slit diaphragm, a therapeutic target of proteinuria
Hiroshi Kawachi et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2020)
Secondary Membranous Nephropathy. A Narrative Review
Gabriella Moroni et al.
FRONTIERS IN MEDICINE (2020)
Curcumin Improves the Renal Autophagy in Rat Experimental Membranous Nephropathy via Regulating the PI3K/AKT/mTOR and Nrf2/HO-1 Signaling Pathways
Qiu Di Tu et al.
BIOMED RESEARCH INTERNATIONAL (2020)
Podocytes and autophagy: a potential therapeutic target in lupus nephritis
Xu-Jie Zhou et al.
AUTOPHAGY (2019)
Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Juergen Floege et al.
KIDNEY INTERNATIONAL (2019)
Targeting PI3K in cancer: mechanisms and advances in clinical trials
Jing Yang et al.
MOLECULAR CANCER (2019)
Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy
F. C. Fervenza et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Treatment of Membranous Nephropathy in Patients With THSD7A Antibodies Using Immunoadsorption
Julia Weinmann-Menke et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2019)
Immunoadsorption in nephrotic syndrome: Where are we now and where are we going from here?
Andreas Kronbichler et al.
ATHEROSCLEROSIS SUPPLEMENTS (2019)
A Cell's Fate: An Overview of the Molecular Biology and Genetics of Apoptosis
Giovanna C. Cavalcante et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Empagliflozin Protects HK-2 Cells from High Glucose-Mediated Injuries via a Mitochondrial Mechanism
Wen-Chin Lee et al.
CELLS (2019)
mTOR Inhibition and Clinical Transplantation: Liver
Bjoern Nashan
TRANSPLANTATION (2018)
Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018
Lorenzo Galluzzi et al.
CELL DEATH AND DIFFERENTIATION (2018)
The Human FSGS-Causing ANLN R431C Mutation Induces Dysregulated PI3K/AKT/mTOR/Rac1 Signaling in Podocytes
Gentzon Hall et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2018)
A Heterologous Model of Thrombospondin Type 1 Domain-Containing 7A-Associated Membranous Nephropathy
Nicola M. Tomas et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
New Insights into Podocyte Biology in Glomerular Health and Disease
Suheir Assady et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Membranous nephropathy: integrating basic science into improved clinical management
Daniel C. Cattran et al.
KIDNEY INTERNATIONAL (2017)
Association of BAFF with PI3K/Akt/mTOR signaling in lupus nephritis
Fengmei Ge et al.
MOLECULAR MEDICINE REPORTS (2017)
Membranous nephropathy associated with hepatitis C virus infection treated with corticosteroids and Ledipasvir-Sofosbuvir: a case report and review of literature
Qinjie Weng et al.
ONCOTARGET (2017)
PLA2R binds to the annexin A2-S100A10 complex in human podocytes
Maryline Fresquet et al.
SCIENTIFIC REPORTS (2017)
Podocyte Autophagy: A Potential Therapeutic Target to Prevent the Progression of Diabetic Nephropathy
Na Liu et al.
JOURNAL OF DIABETES RESEARCH (2017)
Primary Membranous Nephropathy
William G. Couser
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Membranous Nephropathy: A Journey From Bench to Bedside
Jean M. Francis et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2016)
The Mechanistic Target of Rapamycin: The Grand ConducTOR of Metabolism and Aging
Brian K. Kennedy et al.
CELL METABOLISM (2016)
Safety of mTOR inhibitors in adult solid organ transplantation
Pedro Ventura-Aguiar et al.
EXPERT OPINION ON DRUG SAFETY (2016)
Autoantibodies against thrombospondin type 1 domain-containing 7A induce membranous nephropathy
Nicola M. Tomas et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
The Roles of PI3K/AKT/mTOR and MAPK/ERK Signaling Pathways in Human Pheochromocytomas
Juan Du et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2016)
Pharmacological treatment of primary membranous nephropathy in 2016
Anne-Els van de Logt et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2016)
A Meta-Analysis of Antiviral Therapy for Hepatitis B Virus-Associated Membranous Nephropathy
Yue Yang et al.
PLOS ONE (2016)
Long-Term Outcomes in Idiopathic Membranous Nephropathy Using a Restrictive Treatment Strategy
Jan A. J. G. van den Brand et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Thrombospondin Type-1 Domain-Containing 7A in Idiopathic Membranous Nephropathy
Nicola M. Tomas et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
sPLA2 IB induces human podocyte apoptosis via the M-type phospholipase A2 receptor
Yangbin Pan et al.
SCIENTIFIC REPORTS (2014)
Interplay between the Notch and PI3K/Akt pathways in high glucose-induced podocyte apoptosis
Xiao-Mei Wang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2014)
Caspase-8 and Bid: Caught in the act between death receptors and mitochondria
Chahrazade Kantari et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2011)
Membranous nephropathy in systemic lupus erythematosus: a therapeutic enigma
Chi Chiu Mok
NATURE REVIEWS NEPHROLOGY (2009)
M-Type Phospholipase A(sub 2) Receptor as Target Antigen in Idiopathic Membranous Nephropathy.
Laurence H. Beck et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Cardiolipin provides an essential activating platform for caspase-8 on mitochondria
Francois Gonzalvez et al.
JOURNAL OF CELL BIOLOGY (2008)
Mechanisms of angiotensin II signaling on cytoskeleton of podocytes
Hsiang-Hao Hsu et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2008)
FLASH links the CD95 signaling pathway to the cell nucleus and nuclear bodies
Kristijana Milovic-Holm et al.
EMBO JOURNAL (2007)
Curcumin inhibits the mammalian target of rapamycin-mediated signaling pathways in cancer cells
Christopher S. Beevers et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy
S. Fulda et al.
ONCOGENE (2006)
MasterCARD: a priceless link to innate immunity
J Hiscott et al.
TRENDS IN MOLECULAR MEDICINE (2006)
Rapamycin ameliorates proteinuria-associated tubulointerstitial inflammation and fibrosis in experimental membranous nephropathy
RGB Bonegio et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Development of glomerulonephritis during anti-TNF-α therapy for rheumatoid arthritis
MB Stokes et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2005)
Management of membranous nephropathy: When and what for treatment
D Cattran
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Stable expression of nephrin and localization to cell-cell contacts in novel murine podocyte cell lines
D Schiwek et al.
KIDNEY INTERNATIONAL (2004)
Therapy of membranous nephropathy associated with malignancy and secondary causes
JA Jefferson et al.
SEMINARS IN NEPHROLOGY (2003)
Rapamycins - Mechanism of action and cellular resistance
SL Huang et al.
CANCER BIOLOGY & THERAPY (2003)
Brief report - Antenatal membranous glomerulonephritis due to anti-neutral endopeptidase antibodies
H Debiec et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Inactivation of caspase-8 on mitochondria of Bcl-xL-expressing MCF7-Fas cells -: Role for the bifunctional apoptosis regulator protein
AH Stegh et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Rapamycin in transplantation: A review of the evidence
RN Saunders et al.
KIDNEY INTERNATIONAL (2001)
BID-dependent and BID-independent pathways for BAX insertion into mitochondria
SC Ruffolo et al.
CELL DEATH AND DIFFERENTIATION (2000)
Share Paper
